Press release: CB Health Access 2017

Press release

Fourteen health technology companies from Estonia, Latvia, Sweden and Finland to enter the South Korean market

A consortium of Estonian, Latvian, Swedish and Finnish technology organizations initiated the CB Health Access program in 2016, with the purpose to support entrepreneurship in health technologies. CB Health Access facilitates the entry of Estonian, Latvian, Swedish and Finnish health tech companies to distant markets – South Korea, USA, India and Uganda. The program includes a target market introduction, individual coaching, gathering market information, identifying and contacting potential partners, and business missions. 


“This is a great opportunity for companies that want to enter a new market and we expect that the result will be a first customer on the new market for the participants”, says Anna Lefevre Skjöldebrand, CEO at Swedish Medtech, when describing the project.

Fourteen companies from Sweden, Finland, Latvia and Estonia attended a business mission to South Korea in March 2017 to meet with the healthcare actors in Seoul. The business visit was organized in cooperation with BalueCon Inc, and under the framework of CB Health Access, an international EU-funded program.

During the business mission, the participating companies connected with potential distributors, investors, manufacturers as well as regulatory bodies. They also attended the KIMES (Korea International Medical & Hospital Equipment Show) and BioKorea conferences in Seoul, two annual events dedicated to innovation in healthcare. Matchmaking sessions were held at both events, to ensure that the companies would be exposed to as many potential partners as possible.

“The companies’ priority is generally to make new connections, and during the mission they were also provided with a feeling of the South Korean business culture from a local coach”, Anna Riby at Swecare explains when pointing out the benefits for the companies. Several companies have entered negotiations with the contacts they made during the mission, mainly with distributors, but also with investors and manufacturers.

The CB Health Access program was initiated in 2016 between Estonian, Finnish, Latvian and Swedish technology organizations to support entrepreneurship in health technologies. The program facilitates the entry of Estonian, Latvian, Swedish and Finnish health tech companies to distant markets – South Korea, USA, India and Uganda. CB Health Access provides the companies with an introduction of the target market, individual coaching both from the home country and from target market experts, market information, business missions, and identifying and contacting potential partners, and business missions. The program is financed by Central Baltic Interreg Program.

For more information on the CB Health Access program see https://www.cbhealthaccess.eu/, or contact: malin.hollmark (at) swedishmedtech.se